Mã | Lợi suất đáo hạn % | Khối lượng | Giá % | Phiếu giảm giá % | Ngày đáo hạn | Giá trị dư nợ | Giá trị khuôn mặt | Giá trị mệnh giá tối thiểu | Bên phát hành |
---|---|---|---|---|---|---|---|---|---|
117RIGLAXOSMITHKLINE CAPITAL PLC 4.25% GTD SNR EMTN 18/12/45 | 6.06% | 8.46 K | 82.51% | 4.25% | 2045-12-18 | 370.79 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
XXS217060907GLAXOSM.CAP. MTN 20/35MTN | 6.02% | 0 | 71.89% | 1.63% | 2035-05-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | 5.68% | 90 K | 86.72% | 4.20% | 2043-03-18 | 500 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
883GIGLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 10/04/2042 | 5.49% | 0 | 97.88% | 5.25% | 2042-04-10 | 477.82 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
771ZCGLAXOSMITHKLINE CAPITAL PLC 6.375% GTD SNR EMTN 09/03/39 | 5.12% | 0 | 110.38% | 6.38% | 2039-03-09 | 631.3 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | 5.03% | 1.82 M | 110.78% | 6.38% | 2038-05-15 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
UUS377373AH8GLAXOSM.CAP. 19/29 | 4.81% | 0 | 94.73% | 3.38% | 2029-06-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
GGSK4632357GlaxoSmithKline Capital, Inc. 3.625% 15-MAY-2025 | 4.76% | 1.51 M | 99.55% | 3.63% | 2025-05-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
AAG99GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 19/12/2033 | 4.72% | 0 | 103.38% | 5.25% | 2033-12-19 | 574.17 M GBP | 1,000.00 GBP | 1,000.00 GBP | GlaxoSmithKline Capital Plc |
XXS217060184GLAXOSM.CAP. MTN 20/28MTN | 4.71% | 0 | 88.80% | 1.25% | 2028-10-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
UUS377372AN7GLAXOSMITHKLINE CAP.18/28 | 4.57% | 0 | 97.94% | 3.88% | 2028-05-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
772WIGLAXOSMITHKLINE CAPITAL INC 5.375% GTD SNR NTS 15/04/2034 | 4.57% | 0 | 105.28% | 5.38% | 2034-04-15 | 500 M USD | 1,000.00 USD | 1,000.00 USD | GlaxoSmithKline Capital, Inc. |
XXS293369275GSK CAP B.V. 24/36 MTN | 3.20% | 0 | 100.39% | 3.25% | 2036-11-19 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
XXS255381776GSK CAP B.V. 22/32 MTN | 2.96% | 0 | 101.06% | 3.13% | 2032-11-28 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
XXS182282979GLAXOSM.CAP. MTN 18/30MTN | 2.94% | 0 | 94.42% | 1.75% | 2030-05-21 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
GGX5CGLAXOSM.CAP. MTN 05/25 | 2.92% | 0 | 100.53% | 4.00% | 2025-06-16 | 750 M EUR | 1,000.00 EUR | 1,000.00 EUR | GlaxoSmithKline Capital Plc |
XXS293369143GSK CAP B.V. 24/31 MTN | 2.85% | 0 | 100.13% | 2.88% | 2031-11-19 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
XXS168152035GLAXOSM.CAP. MTN 17/29 | 2.65% | 0 | 94.63% | 1.38% | 2029-09-12 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
XXS255381768GSK CAP B.V. 22/27 MTN | 2.63% | 0 | 101.02% | 3.00% | 2027-11-28 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
XXS182282812GLAXOSM.CAP. MTN 18/26MTN | 2.50% | 0 | 98.28% | 1.25% | 2026-05-21 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
GGX5BGLAXOSM.CAP. MTN 17/26 | 2.44% | 0 | 97.60% | 1.00% | 2026-09-12 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
117RNGLAXOSMITHKLINE CAPITAL PLC 3.375% GTD SNR EMTN 20/12/2027 | 0.84% | 0 | 112.19% | 3.38% | 2027-12-20 | 307.77 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
AAQ72GLAXOSMITHKLINE CAPITAL PLC 0.883% GTD SNR EMTN 21/09/20 | — | — | — | 0.88% | 2028-09-21 | 42.5 B JPY | 100,000,000.00 JPY | — | GlaxoSmithKline Capital Plc |